1. Use of risk evaluation and mitigation strategies by the US Food and Drug Administration, 2008-2019.;Guadamuz;JAMA,2020
2. Using a drug-safety tool to prevent competition.;Sarpatwari;N Engl J Med,2014
3. Strategies that delay market entry of generic drugs.;Vokinger;JAMA Intern Med,2017
4. Feeley? J, Bloomfield? D. From nightmare drug to Celgene blockbuster, thalidomide is back. Bloomberg. August 22, 2016. Accessed January 18, 2024. https://www.bloomberg.com/news/articles/2016-08-22/from-nightmare-drug-to-celgene-blockbuster-thalidomide-is-back#xj4y7vzkg
5. Robbins? R. A drug company exploited a safety requirement to make money. New York Times. February 28, 2023. Accessed January 18, 2024. https://www.nytimes.com/2023/02/28/business/jazz-narcolepsy-avadel-patents.html